FindTrial
Sign In

The Role and Molecular Mechanism of PERK-Mediated Kinase-Dependent Necroptosis in Chronic Obstructive Pulmonary Disease

The Role and Molecular Mechanism of PERK-Mediated Kinase-Dependent Necroptosis in Chronic Obstructive Pulmonary Disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500115582
Enrollment
Unknown
Registered
2025-12-29
Start date
2026-01-01
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

Healthy controls:None
COPD group:None

Sponsors

Jiaxing First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.COPD patients diagnosed according to the GOLD guidelines, with no other serious underlying diseases.

Exclusion criteria

Exclusion criteria: 1.Patients with the presence of lung cancer, tuberculosis, asthma, or other major respiratory comorbidities.

Design outcomes

Primary

MeasureTime frame
PERK protein expression;—

Countries

China

Contacts

Public ContactZhou Yunti

Jiaxing First Hospital

18257333157@163.com+86 573 82519999

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026